NDSI
REGN icon

Newman Dignan & Sheerar Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-287
Closed -$182K – 200
2025
Q1 		$182K Sell
287
-25
-8% -$17.2K 0.05% 161
2024
Q4 		$222K Sell
312
-60
-16% -$50.4K 0.06% 164
2024
Q3 		$345K Buy
372
+61
+20% +$67.9K 0.08% 138
2024
Q2 		$327K Sell
311
-167
-35% -$162K 0.08% 138
2024
Q1 		$460K Sell
478
-70
-13% -$66.6K 0.12% 120
2023
Q4 		$481K Buy
548
+55
+11% +$45.3K 0.15% 114
2023
Q3 		$406K Sell
493
-45
-8% -$35.4K 0.13% 118
2023
Q2 		$387K Sell
538
-40
-7% -$30.8K 0.12% 124
2023
Q1 		$475K Sell
578
-40
-6% -$30.2K 0.15% 114
2022
Q4 		$446K Sell
618
-62
-9% -$45.7K 0.15% 118
2022
Q3 		$468 Sell
680
-5
-0.7% -$3.15K 0.07% 111
2022
Q2 		$405K Buy
685
+5
+0.7% +$3.25K 0.14% 124
2022
Q1 		$475 Sell
680
-137
-17% -$86.7K 0.09% 115
2021
Q4 		$516K Buy
+817
New +$502K 0.16% 113
2016
Q1 		– Sell
-411
Closed -$223K – 138
2015
Q4 		$223K Buy
+411
New +$223K 0.16% 133
2015
Q3 		– Sell
-526
Closed -$268K – 146
2015
Q2 		$268K Sell
526
-25
-5% -$12.2K 0.19% 123
2015
Q1 		$249K Sell
551
-25
-4% -$10.6K 0.18% 127
2014
Q4 		$236 Hold
576
– – 0.14% 132
2014
Q3 		$208K Buy
+576
New +$193K 0.16% 137

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Newman Dignan & Sheerar Inc's REGN Position: Q2 2025 in Review

Newman Dignan & Sheerar Inc sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 287 shares — an estimated $182K sold.

Newman Dignan & Sheerar Inc first reported a position in REGN in Q3 2014 and held it in 19 quarters. The position peaked at $516K in Q4 2021. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Newman Dignan & Sheerar Inc reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Newman Dignan & Sheerar Inc sold 287 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $182K.
  • Newman Dignan & Sheerar Inc first reported a position in Regeneron Pharmaceuticals in Q3 2014 and held it in 19 quarters.
  • Newman Dignan & Sheerar Inc's Regeneron Pharmaceuticals position peaked at $516K in Q4 2021.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2025, filed 18 Jul 2025.